(Q44948343)

7 December 2017

title

Levocetirizine: the allergist's arsenal grows larger (English)

1 reference

7 December 2017

R Matthew Bloebaum

1

1 reference

7 December 2017

J Andrew Grant

series ordinal

2

1 reference

7 December 2017

language of work or name

English

0 references

publication date

1 July 2004

1 reference

Expert Opinion on Pharmacotherapy

7 December 2017

published in

1 reference

7 December 2017

volume

5

1 reference

7 December 2017

issue

7

1 reference

7 December 2017

page(s)

1581-1588

1 reference

Definition, classification, and routine diagnosis of urticaria: a consensus report

7 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.7.1581

Antihistamines in late-phase clinical development for allergic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.7.1581

Absorption, distribution, metabolism and excretion of [14C]levocetirizine, the R enantiomer of cetirizine, in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.7.1581

Binding characteristics of cetirizine and levocetirizine to human H(1) histamine receptors: contribution of Lys(191) and Thr(194).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.7.1581

Cetirizine and levocetirizine inhibit eotaxin-induced eosinophil transendothelial migration through human dermal or lung microvascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.7.1581

A randomized, double-blind, crossover comparison among cetirizine, levocetirizine, and ucb 28557 on histamine-induced cutaneous responses in healthy adult volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.7.1581

Comparison of the effects of levocetirizine and loratadine on histamine-induced wheal, flare, and itch in human skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.7.1581

The acute and sub-chronic effects of levocetirizine, cetirizine, loratadine, promethazine and placebo on cognitive function, psychomotor performance, and weal and flare

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.7.1581

Twenty-four-hour activity and consistency of activity of levocetirizine and desloratadine in the skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.7.1581

Effect of cetirizine, levocetirizine, and dextrocetirizine on histamine-induced nasal response in healthy adult volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.7.1581

Absorption and disposition of levocetirizine, the eutomer of cetirizine, administered alone or as cetirizine to healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.7.1581

Blood distribution of levocetirizine, a new non-sedating histamine H1-receptor antagonist, in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.7.1581

Compared pharmacological characteristics in humans of racemic cetirizine and levocetirizine, two histamine H1-receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.7.1581

Levocetirizine is effective for symptom relief including nasal congestion in adolescent and adult (PAR) sensitized to house dust mites

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.7.1581

Comparative in vivo bioactivity of modern H1-antihistamines on AMP challenge in atopic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.7.1581

10.1517/14656566.5.7.1581

21 January 2018

Identifiers

DOI

1 reference

7 December 2017

1 reference